Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Cystic Fibrosis · Hepatitis C

Vertex Pharmaceuticals (Australia)

Vertex Pharmaceuticals (Australia) Pty.

Vertex Pharmaceuticals (Australia) trial registry — 279 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA 02210, US HQ
1989 Founded
6,304 Employees
TGA registrant Type
Company details
Status
Public
HQ
Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA 02210, US
Founded
1989
Employees
6,304
Programs
159
Drugs
64
Patents
991
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Vertex Pharmaceuticals (Australia) clinical trials

Registry index of 279 ClinicalTrials.gov studies linked to Vertex Pharmaceuticals (Australia) programs — each row shows trial ID, program name, phase, status, and indication.

Vertex Pharmaceuticals (Australia) trial registry — 279 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Vertex Pharmaceuticals (Australia).

  1. VX23-670-001 — Phase 2

    Clinical update

  2. VX22-445-122 — Phase 3

    Clinical update

  3. VX24-AIS-D10 — Phase 3

    Clinical update

  4. VX24-993-103 — Phase 2

    Clinical update

  5. VX22-445-123 — Phase 3

    Clinical update

  6. VX21-CTX001-161 — Phase 3

    Clinical update

  7. VX21-CTX001-151 — Phase 3

    Clinical update

  8. VX21-CTX001-141 — Phase 3

    Clinical update

Trial registry

279 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.